Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

RFL

Rafael Holdings Inc

Feb 12 • 04:00PM ET

1.20

0.00 0.00 %

Real Estate • Real Estate Services • USA • NYSE

Peers: OPK CVAC FATE IMTX ALKS AGEN FOLD BPMC ADMA XENE

| Held by: VTI VXF IWC DFAS DFAC DFAT DFUS

Index	-	P/E	-	EPS (ttm)	-0.85	Insider Own	32.62%	Shs Outstand	50.87M	Perf Week	1.69%
Market Cap	62.13M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	34.88M	Perf Month	-3.23%
Enterprise Value	21.25M	PEG	-	EPS next Q	-	Inst Own	7.76%	Short Float	0.15%	Perf Quarter	-5.51%
Income	-31.33M	P/S	60.32	EPS this Y	-	Inst Trans	3.38%	Short Ratio	0.42	Perf Half Y	-27.71%
Sales	1.03M	P/B	0.73	EPS next Y	-	ROA	-32.43%	Short Interest	0.05M	Perf YTD	1.69%
Book/sh	1.65	P/C	1.36	EPS next 5Y	-	ROE	-39.48%	52W High	3.19 -62.38%	Perf Year	-41.12%
Cash/sh	0.88	P/FCF	-	EPS past 3/5Y	44.95% -9.76%	ROIC	-36.76%	52W Low	1.12 7.14%	Perf 3Y	-45.14%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	30.78% -28.51%	Gross Margin	65.21%	Volatility	6.34% 5.39%	Perf 5Y	-96.05%
Dividend TTM	-	EV/Sales	20.63	EPS Y/Y TTM	48.30%	Oper. Margin	-3149.27%	ATR (14)	0.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.98	Sales Y/Y TTM	47.63%	Profit Margin	-3044.70%	RSI (14)	47.73	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	4.00	EPS Q/Q	48.02%	SMA20	-0.17%	Beta	0.60	Target Price	-
Payout	-	Debt/Eq	0.01	Sales Q/Q	87.50%	SMA50	-3.44%	Rel Volume	0.30	Prev Close	1.20
Employees	23	LT Debt/Eq	0.00	Earnings	Dec 11 AMC	SMA200	-18.69%	Avg Volume	125.03K	Price	1.20
IPO	Mar 27, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	38,017	Change	0.00%

Dec-11-25 04:01PM	Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results (GlobeNewswire)
Oct-29-25 04:24PM	Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results (GlobeNewswire)
Oct-28-25 04:01PM	Rafael Holdings Mourns the Passing of Lead Independent Director, Stephen Greenberg, and Announces the Appointment of Alan Grayson to its Board of Directors (GlobeNewswire)
Sep-16-25 08:00AM	Rafael Holdings Announces Presentation of Preliminary Data from Ongoing Phase 3 TransportNPC Open-Label, Single-Arm Sub-Study in Patients Less Than 3 Years Old (GlobeNewswire) +6.77%
Aug-27-25 08:00AM	Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM) (GlobeNewswire)
07:00AM	Loading…
Jun-18-25 07:00AM	Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data (GlobeNewswire) -19.07%
Jun-11-25 07:00AM	Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results (GlobeNewswire) -27.72%
Jun-04-25 04:01PM	Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering (GlobeNewswire) +12.68%
May-20-25 04:01PM	Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol Cyclo (GlobeNewswire)
May-05-25 07:00AM	Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol Cyclo (GlobeNewswire) -7.14%
Apr-29-25 04:30PM	Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol Cyclo (GlobeNewswire) -5.95%
Apr-24-25 04:15PM	Rafael Holdings Strengthens its Focus on the Development of Trappsol Cyclo and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role (GlobeNewswire)
Mar-26-25 06:50AM	Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals (GlobeNewswire)
Mar-13-25 05:50PM	Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results (GlobeNewswire)
Dec-11-24 07:00AM	Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results (GlobeNewswire)
07:14PM	Loading…
Nov-06-24 07:14PM	Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results (GlobeNewswire)
Aug-22-24 06:50AM	Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement (GlobeNewswire)
Jun-14-24 04:01PM	Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results (GlobeNewswire)
May-30-24 09:00AM	Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC Trial of Niemann-Pick Type C1 (Business Wire)
Mar-13-24 05:04PM	Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results (GlobeNewswire)
Dec-14-23 10:51PM	RFL Stock Earnings: Rafael Holdings Reported Results for Q1 2024 (InvestorPlace)
04:01PM	Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results (GlobeNewswire)
Nov-15-23 08:05AM	Cyclo Therapeutics Reports Third Quarter 2023 Financial Results (Business Wire)
Oct-30-23 04:01PM	Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results (GlobeNewswire) +10.97%
Aug-15-23 08:05AM	Cyclo Therapeutics Reports Second Quarter 2023 Financial Results (Business Wire)
Aug-02-23 08:16AM	Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc. (Business Wire)
Jun-13-23 04:01PM	Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update (GlobeNewswire) +7.32%
Jun-05-23 08:05AM	Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement (Business Wire)
May-15-23 08:05AM	Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results (Business Wire)
May-02-23 08:12AM	Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL) (Business Wire)
08:00AM	Loading…
Apr-04-23 08:00AM	Rafael Holdings Announces up to $5 Million Share Repurchase Program (GlobeNewswire) +17.68%
Mar-14-23 04:01PM	Rafael Holdings Reports Second Quarter Fiscal 2023 Financial Results (GlobeNewswire) -8.72%
Dec-13-22 07:00AM	Rafael Holdings Reports First Quarter Fiscal 2023 Financial Results (GlobeNewswire)
Nov-15-22 04:01PM	Rafael Holdings to Focus on Strategic Business Development Initiatives and Curtail Early Stage Development Activities (GlobeNewswire) +6.52%
Oct-31-22 04:01PM	Rafael Holdings Reports Fourth Quarter Fiscal 2022 Financial Results (GlobeNewswire) +9.04%
Sep-28-22 07:00AM	Cornerstone Pharmaceuticals Initiates Phase 1 Trial of CPI-613® (devimistat) in Combination with Chemoradiation for the Treatment of Advanced Pancreatic Cancer (GlobeNewswire)
Aug-23-22 07:43AM	Rafael Holdings Sells its Building Located at 520 Broad Street in Newark, New Jersey and Associated 800-Car Public Garage (GlobeNewswire)
Aug-03-22 08:00AM	Cornerstone Pharmaceuticals Announces Successful Completion of Phase 1b Clinical Trial for CPI-613® (Devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer (GlobeNewswire)
Jul-10-22 08:08AM	Howard Jonas Is The Founder & Chairman of Rafael Holdings, Inc. (NYSE:RFL) And They Just Picked Up 83% More Shares (Simply Wall St.)
Jul-06-22 08:00AM	Cornerstone Pharmaceuticals Strengthens Scientific Advisory Board with the Appointment of Distinguished Scholar Jason Locasale, Ph.D. (GlobeNewswire) -5.88%
Jun-27-22 08:00AM	Cornerstone Pharmaceuticals to Present Pancreatic Cancer Data on CPI-613® (Devimistat) From Its Open-Label Phase 1 Study at the European Society of Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2022 (GlobeNewswire)
Jun-16-22 02:14PM	Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism UPDATE (GlobeNewswire)
08:00AM	Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism (GlobeNewswire)
Jun-14-22 04:01PM	Rafael Holdings Reports Third Quarter Fiscal 2022 Financial Results (GlobeNewswire) -5.88%
Jun-01-22 08:00AM	Cornerstone Pharmaceuticals to Present Pancreatic Cancer, Clear Cell Sarcoma and Biliary Tract Cancer Research Featuring CPI-613® (Devimistat) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
May-24-22 11:04AM	European Medicines Agency Grants Orphan Drug Designation to Cornerstone Pharmaceuticals CPI-613® (Devimistat) for Treatment of Patients with Advanced Unresectable Biliary Tract Cancer (GlobeNewswire)
May-19-22 09:00AM	Rafael Pharmaceuticals, Inc. Announces Corporate Name Change to Cornerstone Pharmaceuticals, Inc. (GlobeNewswire)
Mar-17-22 04:01PM	Rafael Holdings Reports Second Quarter Fiscal 2022 Financial Results (GlobeNewswire) +18.22%
Feb-17-22 12:32PM	Rafael Holdings, Inc. (NYSE:RFL) insider upped their holding by 4.1% earlier this year (Simply Wall St.) -8.61%
Jan-24-22 01:38PM	SkyOak Wealth, LLC Buys iShares Russell 2000 Growth ETF, Vanguard S&P 500 ETF, Vanguard ... (GuruFocus.com)
Jan-21-22 07:00AM	William Bill Conkling to assume the role of Chief Executive Officer as of February 1, 2022 (GlobeNewswire)
Jan-19-22 09:38AM	Adirondack Retirement Specialists, Inc. Buys IDT Corp, Camping World Holdings Inc, Semler ... (GuruFocus.com)
Jan-18-22 08:30AM	Rafael Pharmaceuticals Announces Ongoing Successful Enrollment and Opening of Additional Sites for Phase 2 Clinical Trial of CPI-613® (Devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer (GlobeNewswire) -8.05%
Jan-06-22 08:30AM	Rafael Pharmaceuticals Announces Successful Completion of Dose Escalation with No Dose-Limiting Toxicity (DLT) in First Cohort of APOLLO 613 Phase 1/2 Clinical Trial of CPI-613® (Devimistat) in Patients with Relapsed Clear Cell Sarcoma (GlobeNewswire)
Dec-17-21 09:40AM	Is Rafael Holdings (NYSE:RFL) Using Too Much Debt? (Simply Wall St.)
Dec-15-21 04:30PM	Rafael Holdings Reports First Quarter Fiscal 2022 Financial and Operating Results (GlobeNewswire)
Dec-13-21 08:00AM	Rafael Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) From Phase 2 Clinical Trial for Refractory Burkitt Lymphoma at the 2021 American Society of Hematology (ASH) Annual Meeting and Exposition (GlobeNewswire)
Nov-22-21 07:00AM	Rafael Holdings Realigns Leadership Team to Support Earlier Stage Pipeline Focus (GlobeNewswire) -7.41%
Nov-11-21 09:00AM	Rafael Pharmaceuticals Announces First Patient Enrolled in APOLLO 613 Phase 1/2 Clinical Trial of CPI-613® (Devimistat) in Patients with Relapsed Clear Cell Sarcoma (GlobeNewswire)
Nov-03-21 09:00AM	European Medicines Agency Grants Orphan Drug Designation to Rafael Pharmaceuticals CPI-613® (Devimistat) for Treatment of Patients with Relapsed or Refractory Burkitt's Lymphoma (GlobeNewswire) +5.26%
Oct-29-21 11:00AM	Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Rafael Holdings, Inc. (RFL) Investigation (ACCESSWIRE) -6.55%
Oct-28-21 08:00AM	Rafael Pharmaceuticals Provides Update on Pivotal Phase 3 Clinical Trial in Patients with Metastatic Pancreatic Cancer and Interim Analysis of Pivotal Phase 3 Clinical Trial in Patients with Relapsed or Refractory Acute Myeloid Leukemia (GlobeNewswire) -73.19%
07:00AM	Rafael Holdings Provides Update on Rafael Pharmaceuticals Two Phase 3 Trials of CPI-613® (Devimistat), AVENGER 500 in Metastatic Pancreatic Cancer and ARMADA 2000 in Relapsed or Refractory Acute Myeloid Leukemia (GlobeNewswire)
Oct-25-21 03:05PM	Investing in Rafael Holdings (NYSE:RFL) three years ago would have delivered you a 271% gain (Simply Wall St.)
Oct-20-21 02:17AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates GTS, RFL, ACBI, HOMB; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Oct-18-21 05:41PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation into the Fairness of the Merger of Rafael Holdings, Inc. with Rafael Pharmaceuticals, Inc. (Newsfile)
05:30PM	Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 (GlobeNewswire)
04:30PM	Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2021 Financial and Operating Results and Provides Business Update (GlobeNewswire)
Oct-13-21 03:32PM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates COLB, ESXB, RFL, CLDB, VICI; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Oct-12-21 01:45PM	MERGER ALERT - INOV, and RFL: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies (ACCESSWIRE)
Oct-06-21 06:30AM	Rafael Holdings Appoints Mimi Huizinga, MD, MPH as Chief Development and Medical Officer (PR Newswire) +6.09%
Sep-27-21 08:00AM	Rafael Pharmaceuticals Announces APOLLO613 Phase I/II Clinical Trial of CPI-613® (devimistat) in Combination with Hydroxychloroquine in Patients with Relapsed Clear Cell Sarcoma Begins Enrollment at City of Hope in Duarte, Calif. (GlobeNewswire)
Sep-24-21 04:30PM	Rafael Holdings Continues to Expand its Management Team with a Highly Experienced Global Biopharmaceutical Executive to Build a Fully Integrated Cancer Metabolism Therapeutics Company and Announces Inducement Grant Under NYSE Rule 303A.08 (PR Newswire) -6.25%
Sep-17-21 04:01PM	Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 (PR Newswire)
Sep-14-21 08:27AM	Rafael Holdings Appoints Patrick Fabbio as Chief Financial Officer (PR Newswire)
Sep-11-21 04:55PM	INVESTIGATION: Halper Sadeh LLP Investigates GTS, RFL, NLOK, MDLA, STMP, GPX; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Sep-09-21 05:45PM	MERGER ALERT INOV, GNOG, and RFL: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies (ACCESSWIRE)
Sep-04-21 11:47AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates HRC, RAVN, RFL, STMP; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Sep-02-21 12:30PM	MERGER ALERT - GNOG, and RFL: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies (ACCESSWIRE)
Sep-01-21 11:55AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RFL, SAFM, SNR; Shareholders are Encouraged to Contact the Firm (ACCESSWIRE)
Aug-30-21 04:30PM	NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: Rafael Holdings, Inc. (NYSE:RFL), American National Group, Inc. (NASDAQ:ANAT), Veoneer, Inc. (NYSE:VNE) (ACCESSWIRE) -8.82%
10:14AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RFL, CSOD, VICI, SIC; Shareholders are Encouraged to Contact the Firm (GlobeNewswire)
Aug-27-21 11:45AM	MERGER ALERT - GNOG, RFL, and SC: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies (ACCESSWIRE)
Aug-26-21 05:10PM	SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Rafael Holdings, Inc. (NYSE:RFL) (ACCESSWIRE) +9.19%
04:25PM	INVESTIGATION: Halper Sadeh LLP Investigates RFL, FIVN, MDLA, CMO, SNR; Shareholders are Encouraged to Contact the Firm (PR Newswire)
01:24PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Rafael Holdings, Inc. with Rafael Pharmaceuticals, Inc. (Newsfile)
11:51AM	One Rafael Holdings, Inc. (NYSE:RFL) insider upped their stake by 2,030% in the previous year (Simply Wall St.)
11:20AM	Kaskela Law LLC Announces Investigation of Rafael Holdings, Inc. on Behalf of Stockholders - RFL (ACCESSWIRE)
08:00AM	President and CEO of Rafael Pharmaceuticals, Sanjeev Luther, to Present at the 11th Annual World Orphan Drug Congress USA 2021 (GlobeNewswire)
Aug-25-21 10:00AM	Rafael Pharmaceuticals Announces the Successful Completion of Phase 1b Clinical Trial and Initiates Phase 2 for CPI-613® (devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer (GlobeNewswire) +18.49%
Aug-24-21 04:01PM	Rafael Holdings Announces Closing of $104.2 Million Private Placement (PR Newswire) -6.74%
11:30AM	SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Rafael Holdings, Inc. (NYSE - RFL) (ACCESSWIRE)
Aug-20-21 07:00AM	Rafael Holdings Announces $104.2 Million Private Placement (PR Newswire) -13.15%
Aug-19-21 04:17PM	ALERT: Halper Sadeh LLP Investigates ALTA, TGRF, RFL, HFC, MNR; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Aug-18-21 11:56AM	SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of RIVE, IACB, BCYP, and RFL Mergers (GlobeNewswire)
Aug-17-21 10:11AM	Rafael Holdings Expands Leadership Team with Three Highly Experienced Global Biopharmaceutical Executives to Build a Fully Integrated Cancer Metabolism Therapeutics Company (PR Newswire)
Aug-16-21 08:17AM	INVESTIGATION: Halper Sadeh LLP Investigates ALTA, TGRF, RFL, CLDB; Shareholders are Encouraged to Contact the Firm (GlobeNewswire)
08:01AM	RAFAEL (RFL) STOCKHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Rafael Holdings, Inc. (Business Wire)
12:00AM	SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Rafael Holdings, Inc. (RFL) and Encourages Stockholders to Contact the Firm (GlobeNewswire)
Aug-12-21 08:29PM	NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: Rafael Holdings, Inc. (NYSE:RFL), American National Group, Inc. (NASDAQ:ANAT), Intersect ENT, Inc. (NASDAQ:XENT) (ACCESSWIRE)

Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. It operates through the following segments: Healthcare, Infusion Technology, and Real Estate. The Healthcare segment relates to the activities of LipoMedix, Barer, Farber, and Rafael Medical Devices. The Infusion Technology segment manages equity interest on Day Three. The Real Estate segment refers to the company's real estate holdings. The company was founded in 2017 and is headquartered in Newark, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JONAS HOWARD S	Exec Chairman, CEO & President	Jun 05 '25	Buy	1.28	13,080,457	16,742,985	12,299,207	Jun 09 05:19 PM

Open in Screener

IDT

IDT Corp

Feb 12 • 04:00PM ET

47.76

-0.57 -1.18 %

Communication Services • Telecom Services • USA • NYSE

Peers: T VZ TMUS CMCSA CHTR LUMN CNSL SHEN VIV TU

| Held by: VTI IWM VXF IWO SCHA VOX VTWO DFAS FNDA CALF

Index	RUT	P/E	14.85	EPS (ttm)	3.22	Insider Own	18.67%	Shs Outstand	23.50M	Perf Week	-1.49%
Market Cap	1.20B	Forward P/E	11.79	EPS next Y	4.05	Insider Trans	-1.28%	Shs Float	20.39M	Perf Month	-6.43%
Enterprise Value	882.27M	PEG	0.90	EPS next Q	0.90	Inst Own	55.62%	Short Float	1.32%	Perf Quarter	-8.66%
Income	81.21M	P/S	0.96	EPS this Y	17.87%	Inst Trans	1.33%	Short Ratio	1.56	Perf Half Y	-24.35%
Sales	1.24B	P/B	3.73	EPS next Y	7.71%	ROA	13.43%	Short Interest	0.27M	Perf YTD	-6.74%
Book/sh	12.79	P/C	3.48	EPS next 5Y	13.14%	ROE	27.94%	52W High	71.12 -32.85%	Perf Year	0.17%
Cash/sh	13.72	P/FCF	12.55	EPS past 3/5Y	43.15% 29.99%	ROIC	25.25%	52W Low	45.07 5.97%	Perf 3Y	52.44%
Dividend Est.	-	EV/EBITDA	6.56	Sales past 3/5Y	-3.35% -1.76%	Gross Margin	36.70%	Volatility	2.87% 2.60%	Perf 5Y	137.26%
Dividend TTM	0.24 (0.50%)	EV/Sales	0.71	EPS Y/Y TTM	10.02%	Oper. Margin	9.11%	ATR (14)	1.36	Perf 10Y	477.09%
Dividend Ex-Date	Dec 15, 2025	Quick Ratio	1.78	Sales Y/Y TTM	2.52%	Profit Margin	6.52%	RSI (14)	41.66	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.78	EPS Q/Q	30.51%	SMA20	-1.90%	Beta	0.77	Target Price	80.00
Payout	7.31%	Debt/Eq	0.01	Sales Q/Q	4.26%	SMA50	-4.70%	Rel Volume	0.99	Prev Close	48.33
Employees	1925	LT Debt/Eq	0.00	Earnings	Dec 04 AMC	SMA200	-15.11%	Avg Volume	172.40K	Price	47.76
IPO	Jun 01, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.82% 4.79%	Trades		Volume	171,146	Change	-1.18%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-07-13	Downgrade	Chardan Capital Markets	Buy → Hold
May-15-13	Reiterated	Chardan Capital Markets	Buy	$15 → $18
Apr-23-08	Upgrade	Stanford Research	Sell → Hold
Mar-12-08	Reiterated	Stanford Research	Sell	$6 → $4
Oct-12-07	Reiterated	Stanford Research	Sell	$8 → $6
Oct-05-07	Reiterated	Stanford Research	Sell	$10 → $8
Jun-07-07	Downgrade	Stanford Research	Hold → Sell	$10
Jan-23-07	Downgrade	Janco Partners	Buy → Mkt Perform	$17 → $15

Today 08:30AM	BOSS Money App Helps Senders Avoid the New 1% Remittance Tax (GlobeNewswire)
Feb-10-26 08:30AM	NRSInsights' January 2026 Retail Same-Store Sales Report (GlobeNewswire)
Jan-09-26 08:30AM	NRSInsights' December 2025 Retail Same-Store Sales Report (GlobeNewswire)
Dec-10-25 01:01PM	IDT Stock Dips Post Q1 Earnings Despite Strength Across Key Businesses (Zacks)
Dec-09-25 08:00PM	IDT Corp (IDT) Q1 2026 Earnings Call Highlights: Record Profits and Strategic Growth Amid Challenges (GuruFocus.com)
04:30PM	Loading…
04:30PM	NRSInsights' November 2025 Retail Same-Store Sales Report (GlobeNewswire)
Dec-04-25 04:42PM	IDT: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:30PM	IDT Corporation Reports First Quarter Fiscal Year 2026 Results (GlobeNewswire)
Dec-03-25 02:27PM	Delaware Supreme Court Affirms Court of Chancery's Dismissal of Claims Against IDT Related to Straight Path Communications Sale to Verizon (GlobeNewswire)
Nov-17-25 08:30AM	net2phone Launches HIPAA-Compatible Agentic AI Solution for Healthcare (GlobeNewswire)
Nov-14-25 08:30AM	IDT Corporation to Report First Quarter Fiscal Year 2026 Results (GlobeNewswire)
Nov-11-25 08:30AM	National Retail Solutions (NRS) Launches Grubhub Integration (GlobeNewswire)
Nov-07-25 08:30AM	NRSInsights' October 2025 Retail Same-Store Sales Report (GlobeNewswire)
Oct-24-25 11:32AM	The Zacks Analyst Blog Highlights Amazon.com, Wells Fargo, Amgen, IDT and Village Super Market (Zacks)
Oct-23-25 04:41PM	Top Research Reports for Amazon.com, Wells Fargo & Amgen (Zacks)
04:57PM	Loading…
Oct-22-25 04:57PM	IDT Corporation (IDT): A Bear Case Theory (Insider Monkey)
Oct-06-25 04:30PM	NRSInsights' September 2025 Retail Same-Store Sales Report (GlobeNewswire)
Oct-03-25 10:13AM	IDT Stock Slips Following Q4 Earnings Despite Strong Segment Growth (Zacks)
Oct-01-25 05:01PM	IDT Corporation (IDT) Targets $1.3B Revenue by 2028, Backed by Fintech and Cloud Expansion (Insider Monkey)
Sep-30-25 01:01AM	IDT Corp (IDT) Q4 2025 Earnings Call Highlights: Record EBITDA and Digital Expansion Amid Challenges (GuruFocus.com) -18.38%
Sep-29-25 05:16PM	IDT: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:30PM	IDT Corporation Reports Fourth Quarter and Fiscal Year 2025 Results (GlobeNewswire)
Sep-16-25 02:40PM	IDT Corporation to Present at Sidoti September Investor Conference (GlobeNewswire)
Sep-15-25 08:30AM	IDT Corporation to Report Fourth Quarter and Fiscal Year 2025 Results (GlobeNewswire)
Sep-09-25 08:30AM	NRSInsights' August 2025 Retail Same-Store Sales Report (GlobeNewswire)
Aug-31-25 04:12PM	IDT Corporation's (IDT) NRSInsights Reports Strong Sales Growth for July 2025 (Insider Monkey)
Aug-07-25 08:30AM	NRSInsights' July 2025 Retail Same-Store Sales Report (GlobeNewswire)
Aug-04-25 01:38PM	IDT Corporation (IDT): A Bull Case Theory (Insider Monkey)
Jul-16-25 09:19AM	The Zacks Analyst Blog Highlights Amazon.com, Meta Platforms, Shopify, IDT and Nathan's Famous (Zacks)
Jul-15-25 05:06PM	Top Stock Reports for Amazon.com, Meta Platforms & Shopify (Zacks)
08:30AM	Loading…
Jul-08-25 08:30AM	net2phone's AI Agent Named a 2025 AI Agent Product of the Year Award Winner (GlobeNewswire)
Jul-07-25 08:30AM	NRSInsights' June 2025 Retail Same-Store Sales Report (GlobeNewswire)
Jun-24-25 05:50PM	IDT Corporation (IDT): A Bull Case Theory (Insider Monkey)
Jun-23-25 08:30AM	BOSS Money Ranked Highest by Customers Among Money Transfer Companies (GlobeNewswire)
Jun-10-25 11:15AM	IDT Stock Gains Following Strong Q3 Earnings and Margin Expansion (Zacks)
Jun-09-25 04:30PM	IDT Corporation to Present at East Coast IDEAS Investor Conference (GlobeNewswire) -5.30%
08:30AM	NRSInsights' May 2025 Retail Same-Store Sales Report (GlobeNewswire)
Jun-06-25 03:03AM	IDT Corp (IDT) Q3 2025 Earnings Call Highlights: Record Growth in Key Segments Amidst Revenue ... (GuruFocus.com) +14.39%
Jun-05-25 05:07PM	IDT: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:40PM	IDT Corporation Reports Third Quarter 2025 Results (GlobeNewswire)
May-30-25 10:12AM	IDT Corporation to Report Third Quarter 2025 Results (GlobeNewswire)
May-07-25 09:15AM	NRSInsights' April 2025 Retail Same-Store Sales Report (GlobeNewswire)
May-01-25 08:30AM	On Mother's Day, Celebrate Mom with $0-Fee BOSS Money Transfers (GlobeNewswire)
Apr-07-25 09:23AM	NRSInsights' March 2025 Retail Same-Store Sales Report (GlobeNewswire)
Apr-03-25 08:30AM	BOSS Revolution Announces Savings Pass A Monthly Membership Plan (GlobeNewswire)
Mar-28-25 10:36AM	Why IDT Corp. (IDT) Is Surging In 2025? (Insider Monkey)
Mar-18-25 09:00AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
08:30AM	IDT Corporation to Present at Sidoti Investor Conference (GlobeNewswire)
Mar-07-25 01:13PM	Q2 2025 IDT Corp Earnings Call (Thomson Reuters StreetEvents) +10.18%
02:19AM	IDT Corp (IDT) Q2 2025 Earnings Call Highlights: Record Profits and Strategic Growth Initiatives (GuruFocus.com)
Mar-06-25 05:18PM	IDT: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:30PM	IDT Corporation Reports Record Second Quarter 2025 Results (GlobeNewswire)
Mar-05-25 08:30AM	NRSInsights' February 2025 Retail Same-Store Sales Report (GlobeNewswire)
Feb-27-25 09:20AM	net2phone Introduces Advanced AI Agent (GlobeNewswire)
Feb-25-25 08:30AM	IDT Corporation to Report Second Quarter 2025 Results (GlobeNewswire)
Feb-07-25 10:35AM	NRSInsights' January 2025 Retail Same-Store Sales Report (GlobeNewswire)
Feb-06-25 08:30AM	IDT global Inks Preferred Partner Agreement with Haiti's Natcom for International Long-Distance Traffic Management (GlobeNewswire)
Jan-15-25 10:50AM	BOSS Money Expands Remittance Service to Venezuela, Brazil, and Eritrea (GlobeNewswire)
Jan-09-25 08:30AM	NRSInsights' December and Full Year 2024 Retail Same-Store Sales Report (GlobeNewswire)
Jan-07-25 10:25AM	IDT Corporation (IDT): A Bull Case Theory (Insider Monkey)
Jan-03-25 03:31PM	Charter Communications Stock Gets RS Rating Upgrade (Investor's Business Daily)
Dec-11-24 08:30AM	BOSS Money Says 'Thank You' with Zero-Fee Money Transfers for the Holidays (GlobeNewswire)
Dec-09-24 08:30AM	NRSInsights' November 2024 Retail Same-Store Sales Report (GlobeNewswire)
Dec-05-24 12:00PM	IDT Corp (IDT) Q1 2025 Earnings Call Highlights: Record Profits and Strategic Growth Amidst ... (GuruFocus.com) +5.38%
Dec-04-24 04:51PM	IDT: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:36PM	IDT Corporation Reports Record First Quarter 2025 Results (GlobeNewswire)
Nov-27-24 08:30AM	net2phone Named a Leader in Latin American CCaaS by Frost and Sullivan (GlobeNewswire)
08:30AM	net2phone Named a Leader in Latin American CCaaS by Frost & Sullivan (GlobeNewswire)
Nov-22-24 12:23PM	IDT Corporation to Report First Quarter 2025 Results (GlobeNewswire)
Nov-15-24 02:32PM	IDT Corporation to Participate in Southwest IDEAS Investor Conference (GlobeNewswire)
Nov-08-24 08:30AM	NRSInsights' October 2024 Retail Same-Store Sales Report (GlobeNewswire)
Oct-09-24 01:00PM	IDT Corp (IDT) Q4 2024 Earnings Call Transcript Highlights: Record EBITDA and Strong Growth in ... (GuruFocus.com) +21.14%
08:30AM	NRSInsights' September 2024 Retail Same-Store Sales Report (GlobeNewswire)
Oct-08-24 04:30PM	IDT Corporation Reports Fourth Quarter and Fiscal Year 2024 Results (GlobeNewswire)
Sep-23-24 08:30AM	IDT Corporation to Report Fourth Quarter and Fiscal Year 2024 Results (GlobeNewswire)
Sep-09-24 08:30AM	NRSInsights' August 2024 Retail Same-Store Sales Report (GlobeNewswire)
Sep-03-24 11:32PM	Is Danaher Corporation (DHR) the Best Cancer Stock to Buy Now? (Insider Monkey)
Aug-27-24 08:30AM	net2phone Introduces a Single-Pane-of-Glass View for Engaging Business Conversations Across Channels (GlobeNewswire)
Aug-08-24 09:15AM	NRSInsights' July 2024 Retail Same-Store Sales Report (GlobeNewswire)
Jul-08-24 08:30AM	NRSInsights' June 2024 Retail Same-Store Sales Report (GlobeNewswire)
Jun-07-24 09:15AM	NRSInsights' May 2024 Retail Same-Store Sales Report (GlobeNewswire)
Jun-05-24 08:52PM	IDT Stock Earnings: IDT Reported Results for Q3 2024 (InvestorPlace)
04:39PM	IDT: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:30PM	IDT Corporation Reports Third Quarter Fiscal Year 2024 Results (GlobeNewswire)
Jun-04-24 09:10AM	BOSS Money Introduces Domestic Money Transfers; Expands Delivery and Payment Options (GlobeNewswire)
May-20-24 09:30AM	IDT Corporation to Report Third Quarter Fiscal 2024 Results (GlobeNewswire)
May-15-24 08:30AM	BOSS Money Customers Sent Cash Home to Mom at a Record Rate (GlobeNewswire)
May-07-24 08:30AM	NRSInsights' April 2024 Retail Same-Store Sales Report (GlobeNewswire)
Apr-11-24 03:27AM	20 Countries With The Highest Railway Passenger Traffic in The World (Insider Monkey)
Apr-08-24 05:00PM	NRSInsights' March 2024 Retail Same-Store Sales Report (GlobeNewswire)
Mar-12-24 10:30AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
Mar-11-24 10:50AM	IDT Corporation to Present at Sidoti Investor Conference (GlobeNewswire)
Mar-08-24 09:20AM	NRSInsights' February 2024 Retail Same-Store Sales Report (GlobeNewswire)
Mar-07-24 01:29PM	IDT Corp (IDT) Announces Mixed Q2 Fiscal Year 2024 Results with Stable EPS and Revenue Decline (GuruFocus.com)
10:30AM	IDT Corporation (NYSE:IDT) Q2 2024 Earnings Call Transcript (Insider Monkey)
Mar-06-24 10:52PM	IDT Stock Earnings: IDT Reported Results for Q2 2024 (InvestorPlace)
05:58PM	IDT: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:30PM	IDT Corporation Reports Second Quarter Fiscal Year 2024 Results (GlobeNewswire)
Feb-29-24 04:30PM	IDT Corporation to Report Second Quarter Fiscal 2024 Results (GlobeNewswire)
Feb-26-24 09:10AM	NRS Digital Media Launches StrataSelect (GlobeNewswire)

IDT Corp. operates as a holding company. The firm engages in the distribution and market of communications and payment services. It operates through the following segments: Fintech, National Retail Solutions, Net2phone, Traditional Communications, and Corporate. The Fintech segment is involved in international money remittance and related value transfer services. The National Retail Solutions segment refers to an operator of a nationwide POS network providing independent retailers with store management software, electronic payment processing, and other ancillary merchant services. The Net2phone segment consists of net2phone's cloud communications and contact center offerings. The Traditional Communications segment includes IDT Digital Payments, which enables customers to transfer airtime and bundles of airtime, messaging, and data to international and domestic mobile accounts, BOSS Revolution Calling, an international long-distance calling service marketed primarily to immigrant communities in the United States and Canada, and IDT Global, a wholesale provider of international voice and SMS termination and outsourced traffic management solutions to telecoms worldwide. The company was founded by Howard S. Jonas in August 1990 and is headquartered in Newark, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MASON JOYCE J	EVP and Corporate Secretary	Jan 16 '26	Sale	50.28	2,505	125,964	28,708	Jan 20 02:50 PM
PEREIRA BILL	COO & President	Jan 15 '26	Sale	51.17	7,287	372,876	35,213	Jan 20 02:49 PM
ALEXANDER D MASON	Member of affiliate household	Jan 16 '26	Proposed Sale	50.29	2,505	125,964		Jan 16 04:11 PM
FISCHER MARCELO	Chief Financial Officer	Jan 16 '26	Option Exercise	38.43	5,204	199,990	61,147	Jan 16 04:09 PM
FISCHER MARCELO	Chief Financial Officer	Jan 14 '26	Sale	52.03	7,009	364,702	56,863	Jan 16 04:09 PM
FISCHER MARCELO	Chief Financial Officer	Jan 15 '26	Sale	52.04	920	47,879	55,943	Jan 16 04:09 PM
ABILIO PEREIRA	Officer	Jan 15 '26	Proposed Sale	51.17	7,287	372,876		Jan 15 04:22 PM
FISCHER MARCELO	Chief Financial Officer	Jan 08 '26	Sale	52.29	641	33,516	63,872	Jan 12 04:21 PM
MARCELO FISCHER	Officer	Jan 08 '26	Proposed Sale	52.29	21,092	1,102,825		Jan 08 04:25 PM
COSENTINO ERIC F.	Director	Oct 10 '25	Sale	47.61	200	9,523	53	Oct 15 03:38 PM
ERIC COSENTINO	Director	Oct 10 '25	Proposed Sale	47.61	200	9,523		Oct 10 04:10 PM
PEREIRA BILL	COO & President	Oct 02 '25	Sale	49.63	41,933	2,081,168	42,500	Oct 03 04:25 PM
ABILIO PEREIRA	Officer	Oct 02 '25	Proposed Sale	49.63	41,933	2,081,168		Oct 02 04:04 PM
COSENTINO ERIC F.	Director	Jun 16 '25	Sale	67.03	800	53,624	253	Jun 18 02:18 PM
ERIC COSENTINO	Director	Jun 16 '25	Proposed Sale	67.03	800	53,624		Jun 16 04:05 PM
WARTELL DAVID	CHIEF TECHNOLOGY OFFICER	Mar 18 '25	Sale	48.99	10,735	525,882	0	Mar 20 10:38 AM
DAVID WARTELL	Officer	Mar 18 '25	Proposed Sale	48.99	10,735	525,882		Mar 18 04:05 PM
SHEA NADINE	EVP of GLOBAL HUMAN RESOURCES	Feb 25 '25	Option Exercise	49.11	6,750	331,492	11,525	Feb 27 02:03 PM
ASH MENACHEM	EVP of Strategic&Legal Affairs	Feb 25 '25	Option Exercise	49.11	9,374	460,357	56,537	Feb 27 02:02 PM
WARTELL DAVID	CHIEF TECHNOLOGY OFFICER	Feb 25 '25	Option Exercise	49.11	14,374	705,907	14,374	Feb 27 02:02 PM
FISCHER MARCELO	Chief Financial Officer	Feb 25 '25	Option Exercise	49.11	56,250	2,762,438	92,440	Feb 27 02:02 PM
PEREIRA BILL	COO & President	Feb 25 '25	Option Exercise	49.11	100,313	4,926,371	135,526	Feb 27 02:01 PM
SILBERMAN MITCH	CAO & Controller	Feb 25 '25	Option Exercise	49.11	5,157	253,260	6,329	Feb 27 02:01 PM
MASON JOYCE J	EVP and Corporate Secretary	Feb 25 '25	Option Exercise	49.11	4,500	220,995	41,613	Feb 27 02:01 PM

RFL

Rafael Holdings Inc

IDT

IDT Corp

Upgrade your FINVIZ experience